Australian biotech market today 31.03.09

By Kate McDonald
Tuesday, 31 March, 2009

A very flat day on the stock markets today, with the All Ordinaries down 0.2 per cent at 1.30pm. Pharma and biotech indices were one of the few in the positive, rising 0.68 per cent.

Pharmaxis (ASX:PXS) was up 11c to a healthy $1.71.

Cochlear (ASX:COH) and CSL (ASX:CSL) are both up, as is HeartWare (ASX:HIN) and ResMed (ASX:RMD).

Sirtex Medical (ASX:SRX) is down slightly, as is Progen (ASX:PGL).

Less penicillin needed to treat Strep A infection than we thought

It's never been known exactly how much penicillin prevents sore throats — the most...

Stress disrupts emotion control in mental illness

Acute stress may impair key brain functions involved in managing emotions — particularly in...

Organoid platform enables closer study of bat-borne viruses

Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...

Content from other channels on our network

FSANZ approves updated GM food definitions

Cell-cultured quail: coming to a plate near you

Coles awards $3.5m to support Aussie producers

FoodTech Qld sets new sustainable packaging standards

GNT shows how plant-based colours can liven up snacks

Medicare chronic wound care scheme set to benefit 20,000/year

Urinary incontinence and cardiovascular disease risk in women

Pharmacist distraction during dispensing — extent and sources

Ambulance ramping — its "very real potential human consequences"

Could this game wave goodbye to nerve pain?

Mining and steel giants collaborating on steel decarbonisation

WA allocates funding for local manufacture of 'poles and wires'

Increasing sensor life in harsh conditions

ABB receives EPD status for gearless mill drive ring motor

Enabling OT continuous monitoring